DexCom/ US2521311074 /
2024-05-17 9:59:31 PM | Chg. -0.59 | Volume | Bid10:25:01 PM | Ask10:25:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
131.37USD | -0.45% | 207,679 Turnover: 17.78 mill. |
124.25Bid Size: 4 | 145.00Ask Size: 4 | 52.24 bill.USD | - | 93.83 |
GlobeNewswire
04-08
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
01-31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.